Literature DB >> 18083538

Prenatal caffeine assessment: fetal and maternal biomarkers or self-reported intake?

Laura M Grosso1, Elizabeth Triche, Neal L Benowitz, Michael B Bracken.   

Abstract

PURPOSE: We sought to examine associations among measures of caffeine exposure, including maternal urine, umbilical cord blood, and maternal self report.
METHODS: Pregnant women were recruited from 56 obstetric practices and 15 clinics associated with six hospitals in Connecticut and Massachusetts between September 1996 and January 2000; 3633 women were enrolled. Maternal urine throughout pregnancy and umbilical cord blood samples were analyzed for caffeine, paraxanthine, theophylline, and theobromine. Maternal caffeine intake was assessed throughout pregnancy.
RESULTS: Urinary and cord blood biomarkers were correlated with reported intake throughout pregnancy (range r = 0.35-0.66; p < 0.0001). Infants of smokers had greater cord blood concentrations of paraxanthine, reflecting faster caffeine metabolism in smokers, and cord blood paraxanthine levels were more strongly correlated with intake in smokers.
CONCLUSION: Maternal self reported intake may still be the optimal and most valid measure of antenatal caffeine exposure, since biomarkers do not reflect exposure over pregnancy.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18083538      PMCID: PMC2275917          DOI: 10.1016/j.annepidem.2007.11.005

Source DB:  PubMed          Journal:  Ann Epidemiol        ISSN: 1047-2797            Impact factor:   3.797


  12 in total

Review 1.  Caffeine metabolism, genetics, and perinatal outcomes: a review of exposure assessment considerations during pregnancy.

Authors:  Laura M Grosso; Michael B Bracken
Journal:  Ann Epidemiol       Date:  2005-07       Impact factor: 3.797

2.  Heterogeneity in assessing self-reports of caffeine exposure: implications for studies of health effects.

Authors:  Michael B Bracken; Elizabeth Triche; Laura Grosso; Karen Hellenbrand; Kathleen Belanger; Brian P Leaderer
Journal:  Epidemiology       Date:  2002-03       Impact factor: 4.822

3.  Impairment of caffeine clearance by chronic use of low-dose oestrogen-containing oral contraceptives.

Authors:  D R Abernethy; E L Todd
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953

4.  The disposition of caffeine during and after pregnancy.

Authors:  A Aldridge; J Bailey; A H Neims
Journal:  Semin Perinatol       Date:  1981-10       Impact factor: 3.300

5.  Caffeine urinary metabolite ratios as markers of enzyme activity: a theoretical assessment.

Authors:  A Rostami-Hodjegan; S Nurminen; P R Jackson; G T Tucker
Journal:  Pharmacogenetics       Date:  1996-04

6.  Serum caffeine and paraxanthine as markers for reported caffeine intake in pregnancy.

Authors:  M A Klebanoff; R J Levine; R Dersimonian; J D Clemens; D G Wilkins
Journal:  Ann Epidemiol       Date:  1998-02       Impact factor: 3.797

7.  Food sources and intakes of caffeine in the diets of persons in the United States.

Authors:  Carol D Frary; Rachel K Johnson; Min Qi Wang
Journal:  J Am Diet Assoc       Date:  2005-01

8.  Caffeine content of common beverages.

Authors:  M L Bunker; M McWilliams
Journal:  J Am Diet Assoc       Date:  1979-01

9.  Impaired elimination of caffeine by oral contraceptive steroids.

Authors:  R V Patwardhan; P V Desmond; R F Johnson; S Schenker
Journal:  J Lab Clin Med       Date:  1980-04

10.  Caffeine as a metabolic probe: exploration of the enzyme-inducing effect of cigarette smoking.

Authors:  W Kalow; B K Tang
Journal:  Clin Pharmacol Ther       Date:  1991-01       Impact factor: 6.875

View more
  13 in total

1.  Urine excretion of caffeine and select caffeine metabolites is common in the U.S. population and associated with caffeine intake.

Authors:  Michael E Rybak; Maya R Sternberg; Ching-I Pao; Namanjeet Ahluwalia; Christine M Pfeiffer
Journal:  J Nutr       Date:  2015-02-04       Impact factor: 4.798

2.  Interaction between maternal caffeine intake during pregnancy and CYP1A2 C164A polymorphism affects infant birth size in the Hokkaido study.

Authors:  Seiko Sasaki; Mariko Limpar; Fumihiro Sata; Sumitaka Kobayashi; Reiko Kishi
Journal:  Pediatr Res       Date:  2017-05-24       Impact factor: 3.756

3.  Caffeine Intake During Pregnancy in Different Intrauterine Environments and its Association with Infant Anthropometric Measurements at 3 and 6 Months of Age.

Authors:  Thamíris Santos de Medeiros; Juliana Rombaldi Bernardi; Mariana Lopes de Brito; Vera Lucia Bosa; Marcelo Zubaran Goldani; Clécio Homrich da Silva
Journal:  Matern Child Health J       Date:  2017-06

4.  Caffeine Intake During Pregnancy and Risk of Childhood Obesity: A Systematic Review.

Authors:  Natalie C Frayer; Yeonsoo Kim
Journal:  Int J MCH AIDS       Date:  2020-09-19

5.  Osteogenic potential of osteoblasts from neonatal rats born to mothers treated with caffeine throughout pregnancy.

Authors:  Amanda Maria Sena Reis; Lorena Gabriela Rocha Ribeiro; Natália de Melo Ocarino; Alfredo Miranda Goes; Rogéria Serakides
Journal:  BMC Musculoskelet Disord       Date:  2015-02-04       Impact factor: 2.362

6.  Maternal caffeine intake during pregnancy is associated with risk of low birth weight: a systematic review and dose-response meta-analysis.

Authors:  Ling-Wei Chen; Yi Wu; Nithya Neelakantan; Mary Foong-Fong Chong; An Pan; Rob M van Dam
Journal:  BMC Med       Date:  2014-09-19       Impact factor: 8.775

7.  Relation of 24-hour urinary caffeine and caffeine metabolite excretions with self-reported consumption of coffee and other caffeinated beverages in the general population.

Authors:  Dusan Petrovic; Sandrine Estoppey Younes; Menno Pruijm; Belén Ponte; Daniel Ackermann; Georg Ehret; Nicolas Ansermot; Markus Mohaupt; Fred Paccaud; Bruno Vogt; Antoinette Pechère-Bertschi; Pierre-Yves Martin; Michel Burnier; Chin B Eap; Murielle Bochud; Idris Guessous
Journal:  Nutr Metab (Lond)       Date:  2016-11-17       Impact factor: 4.169

8.  Adherence to the Caffeine Intake Guideline during Pregnancy and Birth Outcomes: A Prospective Cohort Study.

Authors:  Amy Peacock; Delyse Hutchinson; Judy Wilson; Clare McCormack; Raimondo Bruno; Craig A Olsson; Steve Allsop; Elizabeth Elliott; Lucinda Burns; Richard P Mattick
Journal:  Nutrients       Date:  2018-03-07       Impact factor: 5.717

9.  Modulation of CYP2E1 metabolic activity in a cohort of confirmed caffeine ingesting pregnant women with preterm offspring.

Authors:  M R Alcorta-García; C N López-Villaseñor; G Sánchez-Ferrer; H Flores-Mendoza; F Castorena-Torres; M A Aguilar-Torres; C M Sepúlveda-Treviño; J A Hernández-Hernández; R C López-Sánchez; V J Lara-Díaz
Journal:  Mol Cell Pediatr       Date:  2020-06-01

10.  HPLC Method for Quantification of Caffeine and Its Three Major Metabolites in Human Plasma Using Fetal Bovine Serum Matrix to Evaluate Prenatal Drug Exposure.

Authors:  Rosa Del Carmen Lopez-Sanchez; Victor Javier Lara-Diaz; Alejandro Aranda-Gutierrez; Jorge A Martinez-Cardona; Jose A Hernandez
Journal:  J Anal Methods Chem       Date:  2018-08-12       Impact factor: 2.193

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.